is imcivree a glp-1 Rhythm Pharmaceuticals' becomes the first FDA-approved treatment for acquired hypothalamic obesity. ㅤ Link in bio. ㅤ #longevity #biotech #healthspan #aging Join Rhythm Pharmaceuticals for the
Description
D., Montoya, M
Tirzepatide is the first in a class of drugs called dual GLP-1/GIP receptor agonists that activate the receptor for another gut hormone, glucose-dependent insulinotropic polypeptide (GIP), in addition to the GLP-1 receptor
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
Duff, C
They do not contain live bacteria, they do not colonize the gut, and they do not produce postbiotic metabolites like P9 or butyrate
Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1 options
Most clinical data focuses on weight loss and glycemic control with standard dosing, not on the safety of extended fasting periods
